Icahn School of Medicine at Mount Sinai students and staff showed off their biceps along with Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, during the Tenth Annual Dean’s Cup Strongest Person Competition on Monday, April 11, in the Aron Hall Gym. This contest included deadlift, bench press, squat, pull-ups, and push-ups. The Dean’s Cup is a week of fun and competition with games for all medical students, including a 3v3 basketball tournament, 5K run, table tennis, pool, soccer, and Ultimate Frisbee. Winners received Icahn School of Medicine sweatshirts, sweatpants, and other prizes.
The Icahn School of Medicine at Mount Sinai’s Bioethics Program hosted its First Annual Medical Student Ethics Conference, a forum designed to provide medical students across the country with an opportunity to discuss and resolve the ethical challenges they may encounter during physician training. A call for abstracts was issued to medical schools in the region and to several academic medicine and medical ethics organizations. Eight students from six medical schools gave poster presentations that examined such topics as “Anatomy and Cadavers as First Patients,” and “Anticipating Obligations as Future Physicians.” Keynote Speakers Vanessa Northington Gamble, MD, PhD, University Professor of Medical Humanities, George Washington University, and Robert Klitzman, MD, Professor of Clinical Psychiatry and Director of the Masters of Bioethics Program, Columbia University Medical Center, discussed, respectively, personal and historical reflections on racism, medicine, and bioethics; and the role reversal experienced when physicians become patients. The conference, funded by The Arnold P. Gold Foundation, took place on Saturday, March 19, and drew 65 participants.
Physicians at The Mount Sinai Hospital were among the first in the nation to implant an investigational device, a fabric and metal mesh tube known as a stent graft, as part of a clinical trial to treat aneurysms located in the thoracic/abdominal area of the aorta. Mount Sinai is one of only six institutions in the nation granted approval by the U.S. Food and Drug Administration to test the safety and initial feasibility of the device in patients.
The stent graft is used to strengthen the inner lining of the aorta—the main artery that carries blood from the heart to organs—in patients where the aortic walls have weakened and caused a balloon-type bulge known as an aneurysm to grow. Once implanted, the device serves to direct blood flow away from the aneurysm, causing it to shrink in size. If not repaired, the aneurysm can rupture and result in life-threatening internal bleeding. Read more
Routine mammograms used for the early detection of breast cancer may also provide women with an early warning of cardiovascular disease, according to a recent study led by Laurie Margolies, MD, Associate Professor of Radiology at the Icahn School of Medicine at Mount Sinai, and Chief of Breast Imaging at the Dubin Breast Center at The Mount Sinai Hospital. Read more
Valerie Ruffin, an Executive Assistant in the Department of Information Technology, thought that drinking homemade fruit juices was a good way to improve her health and lose weight—until she had a physical exam in 2015. “I was in shock when I was told I had diabetes,” she recalls. “My blood work showed extremely high sugar levels, the result of all the fruit juice I was drinking daily.”
Colleague Angela Mazzone, Project Manager III, Department of Information Technology, was similarly surprised when her physical exam uncovered glucose levels consistent with pre-diabetes. She always thought of herself as a healthy eater, and athletic, but the diagnosis forced her to re-examine that perception. She was now a working mom and, in reality, she was devoting less time to exercising and preparing nutritious meals. Read more
The Institute for Advanced Medicine has relocated the Spencer Cox Morningside Clinic to renovated space at 440 West 114th Street and renamed it the Morningside Clinic. The new site provides patients with a more convenient and comfortable setting that includes a spacious waiting room with a television, and a pediatric waiting area. The Morningside Clinic continues to provide patients with HIV/AIDS treatment and other services, including dental, integrative medicine, and behavioral health care. The attendees at a recent ribbon-cutting ceremony (see photo) included, from left: Vani P. Gandhi, MD, Interim Medical Director, Morningside Clinic, and Assistant Clinical Professor, Medicine (Infectious Diseases), Mount Sinai St. Luke’s; Michael P. Mullen, MD, Director, and Matt Baney, Senior Director, Institute for Advanced Medicine; and Judith A. Aberg, MD, Dr. George Baehr Professor of Clinical Medicine, and Division Chief, Infectious Diseases.
Kamini Doobay, a fourth-year medical student at the Icahn School of Medicine at Mount Sinai, played a key role in organizing a recent forum in New York City that featured renowned medical, public health, and academic leaders who convened to examine racial inequities that contribute to poorer health outcomes in communities of color.
The program, “Dismantling Racism in the NYC Health System: The Time is Now,” took place Saturday, March 12, at the CUNY Graduate Center and drew 200 participants. Ms. Doobay worked with Mount Sinai’s Department of Medical Education, the New York City Department of Health and Mental Hygiene, the CUNY Graduate School of Public Health and Health Policy, and other entities to develop the day-long activities. Read more
The Mount Sinai Hospital, including its Manhattan and Queens campuses, recently was named a 2014 Top Performer on Key Quality Measures® by The Joint Commission, the nation’s leading accreditor of health care organizations.
Mount Sinai was the only full-service hospital in Manhattan to achieve this distinction, which signifies its commitment to patient safety and quality-improvement outcomes. Read more
For scientists who study stem cells, the ability to produce hematopoietic stem/progenitor cells (HSPCs) in the lab and then transplant them into patients with blood disorders has been a long-sought-after goal. Recently, the field took a step closer to that milestone when researchers at the Icahn School of Medicine at Mount Sinai identified cells in the embryos and placentas of mice that are actually precursors to HSPCs. Hematopoiesis is the daily process by which the human body generates all of the different types of cells found in the blood and immunological system. Read more
Mount Sinai Brooklyn recently acquired an additional CT scanner to decrease waiting time and expedite results for patients who need immediate testing, such as people who may have had a stroke. Located near the Emergency Department, it features 128-slice technology that provides high-definition imaging details and performs CT angiograms. Among the attendees at a ribbon-cutting ceremony on Thursday, March 31, were, from left: GraceAnn Weick, ANP, MSN, Chief Operating Officer and Vice President, Patient Care Services, Mount Sinai Brooklyn; Burton P. Drayer, MD, Dr. Charles M. and Marilyn Newman Professor and System Chair, Department of Radiology; Lin H. Mo, MBA, MPH, President, Mount Sinai Brooklyn; Carl Ramsay, MD, Vice President, Emergency Medicine Clinical Operations, Mount Sinai Health System; and Scott M. Lorin, MD, Chief Medical Officer, Mount Sinai Brooklyn.